Meet with Element's world-renowned Engaged Experts at the CPhI North America Conference April 30-May 2 in Chicago, IL. Find out about our latest CMS product development & testing, clinical manufacturing, explore our discoveries in drug products delivery and secure your future partnership with us. 

About the event

CPhl is an established pharmaceutical event offering fantastic opportunities to network with over 7,400 attendees, connect with Pharmaceutical players from over 40 countries and learn the latest industry trends at more than 110 hours of educational content. 

More information about the event here.

Why attend? 

Element Wilmington (previously known as Exova SL Pharma), is fully GMP compliant manufacturing and testing facility and has been providing high value and high-quality pharmaceutical CMC product development and quality control testing services focused primarily on parenteral, ophthalmic, intranasal and topical drug products, since 1997.

Element’s pharmaceutical and biotechnology industry leaders, Dr. Pramod Nednoor, Kalyan Potluri and Dr. Jim Scull, VP of our Health Sciences Division will be on hand to discuss end-to-end testing solutions specific to your project needs.

Pramod and Kalyan, based in our Wilmington DE laboratory will be available to provide expert advice on formulation development and full CMC services including Preformulation, CMC and clinical manufacturing services for Parenteral, Ophthalmic, Topical and Oral solutions.

Dr. Jim Scull is a well-known expert and author on extractables and leachables programs and will be meeting with interested firms to discuss their particular project requirements. 

Take this opportunity to drop by our Booth #1614 and meet our experts for consultation. 

Book a Meeting Today! 

Schedule a meeting with one of our Engaged Experts to discuss Element’s comprehensive range of services offered to the Pharmaceutical industry, including:

  • Full CMC Product Development of both Innovative and Generic Drug Products
  • Manufacture of Tox, Phase 1 & Phase 2 Clinical Batches
  • Characterization of molecule and Pre-formulation studies
  • pH/Solubility and Excipients Compatibility studies
  • Formulation Development studies
  • Full analytical and microbiological support for the above
  • Evaluation and selection of Container/Closure systems (vials and syringes)
  • Development and selection of Process and key parameters
  • Development of Master Batch Records
  • QC release and stability testing of marketed products
  • Tech Transfer & Regulatory Documentation (IND, NDA, ANDA)

Our team of over 6,000 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.